Project Bioshield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project bioshield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Bioshield Today - Breaking & Trending Today

Soligenix Announces Reverse Stock Split

/PRNewswire/ Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing. ....

Us Congress , Prnewswire Soligenix Inc , National Institute Of Allergy , Development Authority , Soligenix Inc , Our Public Health Solutions , Equiniti Trust Company , Exchange Commission , Defense Threat Reduction Agency , Biomedical Advanced Research , Company Board Of Directors , Common Stock Will Begin Trading , Split Adjusted Basis , Nasdaq Capital Market , Second Amended , Restated Certificate , Public Health Solutions , National Institute , Infectious Diseases , Project Bioshield , Priority Review Voucher ,

SOLIGENIX, INC.: Soligenix Announces Reverse Stock Split

Common Stock Will Begin Trading on Split-Adjusted Basis on June 6, 2024 PRINCETON, N.J., May 31, 2024 /PRNewswire/ Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical ....

Soligenix Inc , Prnewswire Soligenix Inc , Exchange Commission , Development Authority , Us Congress , Biomedical Advanced Research , Our Public Health Solutions , Company Board Of Directors , Equiniti Trust Company , National Institute Of Allergy , Defense Threat Reduction Agency , Common Stock Will Begin Trading , Split Adjusted Basis , Nasdaq Capital Market , Second Amended , Restated Certificate , Public Health Solutions , National Institute , Infectious Diseases , Project Bioshield , Priority Review Voucher , Ihr Portfolio ,

Soligenix Encourages Stockholders to Vote their Shares at the Annual Meeting

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, encourages its eligible stockholders to vote their. ....

Our Public Health Solutions , Biomedical Advanced Research , Defense Threat Reduction Agency , National Institute Of Allergy , Exchange Commission , Development Authority , Us Securities Exchange , Us Congress , Alliance Advisors , Soligenix Inc , Prnewswire Soligenix Inc , Encourages Stockholders , Annual Meeting , Exchange Act , Principal Stockholders , Public Health Solutions , National Institute , Infectious Diseases , Project Bioshield , Priority Review Voucher ,

Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting

Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Soligenix Inc , Development Authority , Us Congress , Alliance Advisors , Biomedical Advanced Research , Us Securities Exchange , National Institute Of Allergy , Defense Threat Reduction Agency , Our Public Health Solutions , Exchange Commission , Annual Meeting , Exchange Act , Principal Stockholders , Public Health Solutions , National Institute , Infectious Diseases , Project Bioshield , Priority Review Voucher ,

Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split

Soligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Christopherj Schaber , Us Congress , Soligenix Inc , Exchange Commission , Biomedical Advanced Research , National Institute Of Allergy , Alliance Advisors , Us Securities Exchange , Our Public Health Solutions , Development Authority , Defense Threat Reduction Agency , Reverse Stock , Common Stock , Nasdaq Capital Market , Chief Executive Officer , Annual Meeting , Exchange Act , Principal Stockholders , Public Health Solutions , National Institute , Infectious Diseases , Project Bioshield , Priority Review Voucher ,